Clinical Trial Update: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of lanifibranor in adults with nonalcoholic steatohepatitis and fibrosis stages F2-F3 (NATiV3); currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Lanifibranor (lanifibranor)

Snippet

Sponsor: Inventiva Pharma | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING